Aminolevulinic acid
( DrugBank: Aminolevulinic acid / KEGG DRUG: Aminolevulinic acid hydrochloride, Aminolevulinic acid )
6 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 34 | Neurofibromatosis | 2 |
| 54 | Adult still disease | 3 |
| 96 | Crohn disease | 2 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 180 | ATR-X syndrome | 1 |
| 254 | Porphyria | 2 |
| 286 | Hereditary sideroblastic anemia | 2 |
34. Neurofibromatosis
Clinical trials : 179 / Drugs : 259 - (DrugBank : 84) / Drug target genes : 90 - Drug target pathways : 211
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
54. Adult still disease
Clinical trials : 31 / Drugs : 39 - (DrugBank : 15) / Drug target genes : 12 - Drug target pathways : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
96. Crohn disease
Clinical trials : 2,888 / Drugs : 1,678 - (DrugBank : 247) / Drug target genes : 193 - Drug target pathways : 234
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
180. ATR-X syndrome
Clinical trial : 1 / Drug : 1 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
254. Porphyria
Clinical trials : 85 / Drugs : 67 - (DrugBank : 18) / Drug target genes : 18 - Drug target pathways : 28
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
286. Hereditary sideroblastic anemia
Clinical trials : 7 / Drugs : 27 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 40
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|